Absci vs OneMedNet
ABSI and ONMD side by side, both in engineering, accounting, research, management, and related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ABSI and ONMD compare
Absci is the larger company, worth 4.6 times as much as OneMedNet ($1.5B against $317M).
OneMedNet grew revenue faster over the last twelve months (217% versus −47.2% for Absci).
OneMedNet keeps more of each dollar of sales as profit, with a net margin of −584% compared with −8451% at Absci.
Absci scores higher on the StockData Score (5 against 3 for OneMedNet), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ABSI | ONMD |
|---|---|---|
| Size and price | ||
| Market cap | $1.5B | $317M |
| Share price | $8.45 | $5.34 |
| Change, 1 year | 149% | −64.6% |
| Change, 5 years | −23.5% | −94.7% |
| Beta (5Y) | 2.19 | −0.24 |
| Employees | 140 | 23 |
| StockData Score | ||
| Total score | 5 (better) | 3 |
| Valuation score | 0 | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 5 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 975× | 217× (better) |
| P/B | 6.6× | – |
| FCF yield | −7.8% | −2.2% (better) |
| Growth | ||
| Revenue growth (TTM) | −47.2% | 217% (better) |
| Revenue growth, 5Y average | −10.1% | – |
| Profitability | ||
| Gross margin | – | −68.8% |
| Operating margin | −8812% | −696% (better) |
| Net margin | −8451% | −584% (better) |
| FCF margin | −7563% | −473% (better) |
| Return on equity | −58.6% | – |
| Return on invested capital | −242% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | −2569.4× | −307.0× (better) |
| Current ratio | 9.64 (better) | 0.28 |
| Altman Z-score | 36.44 (better) | −99.41 |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | −7.6% | – |
| Shareholder yield | −7.6% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 88.3% | 10.2% |
| Held by insiders | 15.5% | 6.9% |
| Insider net buying, 12 months | $801K | $4.1M (better) |
| Short interest, % of float | 24.7% | – |
Go deeper
- ABSI stock overview
- ABSI income statement
- ABSI valuation and score
- ONMD stock overview
- ONMD income statement
- ONMD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.